Reports by Industry
Reports by Company
- Company Analysis(173)
- Company Profile(60)
Ukraine Emerging as Attractive Clinical Trial Destination in Europe
Jan 27, 2009
According to “Ukraine Pharma - New Opportunities for Growth”, a new research study by RNCOS, conducting clinical trials in the US and western European countries has become an expensive and time consuming affair, and Ukraine can present drug manufacturers with a suitable alternative. With a population of more than 46 Million in 2007, the country represents the second largest patient pool (after Russia) in Eastern Europe, that makes it easier and faster to recruit patients.
Another major feature which helps in the quick recruitment of patients in Ukraine is its healthcare system. Both Primary and specialist care is structured around big hospitals and encompasses a large population. The system has a centralized structure and vertical referral system, which implies that principal investigators can recruit patients from the regional population without any competition inside.
Moreover, Ukraine’s strong healthcare infrastructure also gives it an extra edge over its neighboring countries in conducting clinical trials. In 2007, there were 9.8 doctors and 4.8 hospital beds for every thousand people, which is larger not only by developing country standards but also by Western European standards. Clinical trials are also expected to guarantee free of charge treatment to trial patients, and with a sizeable population still unable to afford costly medications, the number of potential patients participating in clinical trials is expected to be large.
Fast patient recruitment and strong healthcare infrastructure are just few of the many benefits Ukraine offers. “Ukraine Pharma - New Opportunities for Growth” outlines other major attractions of the country. It gives an extensive and objective analysis on the pharmaceutical market in Ukraine. The report investigates both the past and present trends in the pharmaceutical market, but its focus is on the future trends shaping the industry.
This research thoroughly investigates the performance of both the retail and hospital segments of the pharmaceutical market. Based on various present and future indicators, the future outlook of the various segments of the market has been fully analyzed. The report can thus give valuable information for manufacturers/investors considering entering the Ukrainian pharmaceutical market.
For more information visit: http://www.rncos.com/Report/IM161.htm
Some of our Related Reports are as follows:Â
Related Releases are as follows:
- Green Go to Derma Clinical Trial - How will it Shape Industry?
- Liquid Biopsy Paving the Way to Growth through Strategic Transactions
- India- A Largely Untapped Market for NIPT
- Government Initiatives Promoting the Indian Healthcare Sector
- Clinical Chemistry Testing Major Driver for US Clinical Laboratory Testing Market
Media Citation
- testtest
19 Jan, 2024 - Yourstory.com News @ Foodtech startup Swiggy launches Health Hub in Chennai
23 Mar, 2021 - Yourstory.com News @ Zomato forays into dietary supplements, makes its own 'made in India' brand
16 Mar, 2021 - View more
get in touch
Copyright © 2014, RNCOS, 2002-2014
About Us
Terms & Policy
Contact